MovDisordV3, PascalFrancis, Corpus, bibRecord, 002B14

Estrogen use among nursing home residents with a diagnosis of Parkinson's disease

Identifieur interne : 002B14 ( PascalFrancis/Corpus ); précédent : 002B13; suivant : 002B15

Estrogen use among nursing home residents with a diagnosis of Parkinson's disease

Auteurs : Hubert H. Fernandez ; Kate L. Lapane

Source :

Movement disorders [ 0885-3185 ] ; 2000.

RBID : Pascal:01-0016453

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Oestrogène, Utilisation, Etablissement troisième âge, Démence, Capacité fonctionnelle, Mortalité, Etat dépressif, Etude comparative, Traitement substitutif, Epidémiologie, Personne âgée, Hormonothérapie.

English descriptors

KwdEn :
- Comparative study, Dementia, Depression, Elderly, Epidemiology, Estrogen, Functional capacity, Homes for the aged, Hormon replacement therapy, Mortality, Parkinson disease, Replacement therapy, Use.

Abstract

BACKGROUND: The role of estrogen in motor, cognitive, and behavioral functions in Parkinson's disease (PD) remains unclear. OBJECTIVES/METHODS: To determine differences in functional, cognitive, and behavioral patterns between estrogen users and non-users, we performed an observational study on 10,145 elderly women with PD using the Systematic Assessment in Geriatric drug use via Epidemiology (SAGE) database. The SAGE database consists of the Minimum Data Set (MDS), data collected on a cross-section of over 400,000 nursing home (NH) residents in five US states. Using a cross-sectional study design, we evaluated the demographics, physical and cognitive function, and mortality rates of women with PD who received estrogen (n = 195) versus those who did not receive estrogen (n = 9950). RESULTS: Independent of age, estrogen users were less cognitively impaired and more independent in their activities of daily living. Surprisingly, more estrogen users were depressed and more likely to be on an antidepressant than non-users. One-year death rates were comparable between estrogen users and non-users. CONCLUSION: This study supports the growing number of recent data suggesting estrogen's potential beneficial effects on PD motor and cognitive functions.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 15`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Estrogen use among nursing home residents with a diagnosis of Parkinson's disease`
A11	`01`	`1`		`@1 FERNANDEZ (Hubert H.)`
A11	`02`	`1`		`@1 LAPANE (Kate L.)`
A14	`01`			`@1 Department of Clinical Neurosciences and Center for Gerontology and Health Care Research, Brown University School of Medicine @2 Providence, Rhode Island @3 USA @Z 1 aut.`
A14	`02`			`@1 Division of Neurology, Memorial Hospital of Rhode Island @2 Rhode Island @3 USA @Z 1 aut.`
A14	`03`			`@1 Department of Community Health and Center for Gerontology and Health Care Research, Brown University School of Medicine @2 Providence, Rhode Island @3 USA @Z 2 aut.`
A20				`@1 1119-1124`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000092814950090`
A44				`@0 0000 @1 © 2001 INIST-CNRS. All rights reserved.`
A45				`@0 96 ref.`
A47	`01`	`1`		`@0 01-0016453`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 BACKGROUND: The role of estrogen in motor, cognitive, and behavioral functions in Parkinson's disease (PD) remains unclear. OBJECTIVES/METHODS: To determine differences in functional, cognitive, and behavioral patterns between estrogen users and non-users, we performed an observational study on 10,145 elderly women with PD using the Systematic Assessment in Geriatric drug use via Epidemiology (SAGE) database. The SAGE database consists of the Minimum Data Set (MDS), data collected on a cross-section of over 400,000 nursing home (NH) residents in five US states. Using a cross-sectional study design, we evaluated the demographics, physical and cognitive function, and mortality rates of women with PD who received estrogen (n = 195) versus those who did not receive estrogen (n = 9950). RESULTS: Independent of age, estrogen users were less cognitively impaired and more independent in their activities of daily living. Surprisingly, more estrogen users were depressed and more likely to be on an antidepressant than non-users. One-year death rates were comparable between estrogen users and non-users. CONCLUSION: This study supports the growing number of recent data suggesting estrogen's potential beneficial effects on PD motor and cognitive functions.
C02	`01`	`X`		`@0 002B02O`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Oestrogène @5 04`
C03	`02`	`X`	`ENG`	`@0 Estrogen @5 04`
C03	`02`	`X`	`SPA`	`@0 Estrógeno @5 04`
C03	`03`	`X`	`FRE`	`@0 Utilisation @5 05`
C03	`03`	`X`	`ENG`	`@0 Use @5 05`
C03	`03`	`X`	`SPA`	`@0 Utilización @5 05`
C03	`04`	`X`	`FRE`	`@0 Etablissement troisième âge @5 07`
C03	`04`	`X`	`ENG`	`@0 Homes for the aged @5 07`
C03	`04`	`X`	`SPA`	`@0 Establecimiento tercera edad @5 07`
C03	`05`	`X`	`FRE`	`@0 Démence @5 10`
C03	`05`	`X`	`ENG`	`@0 Dementia @5 10`
C03	`05`	`X`	`SPA`	`@0 Demencia @5 10`
C03	`06`	`X`	`FRE`	`@0 Capacité fonctionnelle @5 13`
C03	`06`	`X`	`ENG`	`@0 Functional capacity @5 13`
C03	`06`	`X`	`SPA`	`@0 Capacidad funcional @5 13`
C03	`07`	`X`	`FRE`	`@0 Mortalité @5 14`
C03	`07`	`X`	`ENG`	`@0 Mortality @5 14`
C03	`07`	`X`	`SPA`	`@0 Mortalidad @5 14`
C03	`08`	`X`	`FRE`	`@0 Etat dépressif @5 15`
C03	`08`	`X`	`ENG`	`@0 Depression @5 15`
C03	`08`	`X`	`SPA`	`@0 Estado depresivo @5 15`
C03	`09`	`X`	`FRE`	`@0 Etude comparative @5 17`
C03	`09`	`X`	`ENG`	`@0 Comparative study @5 17`
C03	`09`	`X`	`SPA`	`@0 Estudio comparativo @5 17`
C03	`10`	`X`	`FRE`	`@0 Traitement substitutif @5 18`
C03	`10`	`X`	`ENG`	`@0 Replacement therapy @5 18`
C03	`10`	`X`	`SPA`	`@0 Tratamiento sustitutivo @5 18`
C03	`11`	`X`	`FRE`	`@0 Epidémiologie @5 19`
C03	`11`	`X`	`ENG`	`@0 Epidemiology @5 19`
C03	`11`	`X`	`SPA`	`@0 Epidemiología @5 19`
C03	`12`	`X`	`FRE`	`@0 Personne âgée @5 20`
C03	`12`	`X`	`ENG`	`@0 Elderly @5 20`
C03	`12`	`X`	`SPA`	`@0 Anciano @5 20`
C03	`13`	`X`	`FRE`	`@0 Hormonothérapie @4 CD @5 96`
C03	`13`	`X`	`ENG`	`@0 Hormon replacement therapy @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`05`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`06`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`06`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`06`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`07`	`X`	`FRE`	`@0 Trouble neurologique @5 61`
C07	`07`	`X`	`ENG`	`@0 Neurological disorder @5 61`
C07	`07`	`X`	`SPA`	`@0 Trastorno neurológico @5 61`
C07	`08`	`X`	`FRE`	`@0 Trouble cognition @5 62`
C07	`08`	`X`	`ENG`	`@0 Cognitive disorder @5 62`
C07	`08`	`X`	`SPA`	`@0 Trastorno cognitivo @5 62`
C07	`09`	`X`	`FRE`	`@0 Trouble humeur @5 69`
C07	`09`	`X`	`ENG`	`@0 Mood disorder @5 69`
C07	`09`	`X`	`SPA`	`@0 Trastorno humor @5 69`
N21				`@1 008`

Format Inist (serveur)

NO :	PASCAL 01-0016453 INIST
ET :	Estrogen use among nursing home residents with a diagnosis of Parkinson's disease
AU :	FERNANDEZ (Hubert H.); LAPANE (Kate L.)
AF :	Department of Clinical Neurosciences and Center for Gerontology and Health Care Research, Brown University School of Medicine/Providence, Rhode Island/Etats-Unis (1 aut.); Division of Neurology, Memorial Hospital of Rhode Island/Rhode Island/Etats-Unis (1 aut.); Department of Community Health and Center for Gerontology and Health Care Research, Brown University School of Medicine/Providence, Rhode Island/Etats-Unis (2 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2000; Vol. 15; No. 6; Pp. 1119-1124; Bibl. 96 ref.
LA :	Anglais
EA :	BACKGROUND: The role of estrogen in motor, cognitive, and behavioral functions in Parkinson's disease (PD) remains unclear. OBJECTIVES/METHODS: To determine differences in functional, cognitive, and behavioral patterns between estrogen users and non-users, we performed an observational study on 10,145 elderly women with PD using the Systematic Assessment in Geriatric drug use via Epidemiology (SAGE) database. The SAGE database consists of the Minimum Data Set (MDS), data collected on a cross-section of over 400,000 nursing home (NH) residents in five US states. Using a cross-sectional study design, we evaluated the demographics, physical and cognitive function, and mortality rates of women with PD who received estrogen (n = 195) versus those who did not receive estrogen (n = 9950). RESULTS: Independent of age, estrogen users were less cognitively impaired and more independent in their activities of daily living. Surprisingly, more estrogen users were depressed and more likely to be on an antidepressant than non-users. One-year death rates were comparable between estrogen users and non-users. CONCLUSION: This study supports the growing number of recent data suggesting estrogen's potential beneficial effects on PD motor and cognitive functions.
CC :	002B02O
FD :	Parkinson maladie; Oestrogène; Utilisation; Etablissement troisième âge; Démence; Capacité fonctionnelle; Mortalité; Etat dépressif; Etude comparative; Traitement substitutif; Epidémiologie; Personne âgée; Hormonothérapie
FG :	Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Trouble neurologique; Trouble cognition; Trouble humeur
ED :	Parkinson disease; Estrogen; Use; Homes for the aged; Dementia; Functional capacity; Mortality; Depression; Comparative study; Replacement therapy; Epidemiology; Elderly; Hormon replacement therapy
EG :	Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Neurological disorder; Cognitive disorder; Mood disorder
SD :	Parkinson enfermedad; Estrógeno; Utilización; Establecimiento tercera edad; Demencia; Capacidad funcional; Mortalidad; Estado depresivo; Estudio comparativo; Tratamiento sustitutivo; Epidemiología; Anciano
LO :	INIST-20953.354000092814950090
ID :	01-0016453

Links to Exploration step

Pascal:01-0016453

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Estrogen use among nursing home residents with a diagnosis of Parkinson's disease</title>
<author><name sortKey="Fernandez, Hubert H" sort="Fernandez, Hubert H" uniqKey="Fernandez H" first="Hubert H." last="Fernandez">Hubert H. Fernandez</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Clinical Neurosciences and Center for Gerontology and Health Care Research, Brown University School of Medicine</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Division of Neurology, Memorial Hospital of Rhode Island</s1>
<s2>Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lapane, Kate L" sort="Lapane, Kate L" uniqKey="Lapane K" first="Kate L." last="Lapane">Kate L. Lapane</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Community Health and Center for Gerontology and Health Care Research, Brown University School of Medicine</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">01-0016453</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 01-0016453 INIST</idno>
<idno type="RBID">Pascal:01-0016453</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002B14</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Estrogen use among nursing home residents with a diagnosis of Parkinson's disease</title>
<author><name sortKey="Fernandez, Hubert H" sort="Fernandez, Hubert H" uniqKey="Fernandez H" first="Hubert H." last="Fernandez">Hubert H. Fernandez</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Clinical Neurosciences and Center for Gerontology and Health Care Research, Brown University School of Medicine</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Division of Neurology, Memorial Hospital of Rhode Island</s1>
<s2>Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lapane, Kate L" sort="Lapane, Kate L" uniqKey="Lapane K" first="Kate L." last="Lapane">Kate L. Lapane</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Community Health and Center for Gerontology and Health Care Research, Brown University School of Medicine</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Comparative study</term>
<term>Dementia</term>
<term>Depression</term>
<term>Elderly</term>
<term>Epidemiology</term>
<term>Estrogen</term>
<term>Functional capacity</term>
<term>Homes for the aged</term>
<term>Hormon replacement therapy</term>
<term>Mortality</term>
<term>Parkinson disease</term>
<term>Replacement therapy</term>
<term>Use</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Oestrogène</term>
<term>Utilisation</term>
<term>Etablissement troisième âge</term>
<term>Démence</term>
<term>Capacité fonctionnelle</term>
<term>Mortalité</term>
<term>Etat dépressif</term>
<term>Etude comparative</term>
<term>Traitement substitutif</term>
<term>Epidémiologie</term>
<term>Personne âgée</term>
<term>Hormonothérapie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: The role of estrogen in motor, cognitive, and behavioral functions in Parkinson's disease (PD) remains unclear. OBJECTIVES/METHODS: To determine differences in functional, cognitive, and behavioral patterns between estrogen users and non-users, we performed an observational study on 10,145 elderly women with PD using the Systematic Assessment in Geriatric drug use via Epidemiology (SAGE) database. The SAGE database consists of the Minimum Data Set (MDS), data collected on a cross-section of over 400,000 nursing home (NH) residents in five US states. Using a cross-sectional study design, we evaluated the demographics, physical and cognitive function, and mortality rates of women with PD who received estrogen (n = 195) versus those who did not receive estrogen (n = 9950). RESULTS: Independent of age, estrogen users were less cognitively impaired and more independent in their activities of daily living. Surprisingly, more estrogen users were depressed and more likely to be on an antidepressant than non-users. One-year death rates were comparable between estrogen users and non-users. CONCLUSION: This study supports the growing number of recent data suggesting estrogen's potential beneficial effects on PD motor and cognitive functions.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>15</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Estrogen use among nursing home residents with a diagnosis of Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>FERNANDEZ (Hubert H.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LAPANE (Kate L.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Clinical Neurosciences and Center for Gerontology and Health Care Research, Brown University School of Medicine</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Division of Neurology, Memorial Hospital of Rhode Island</s1>
<s2>Rhode Island</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Community Health and Center for Gerontology and Health Care Research, Brown University School of Medicine</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>1119-1124</s1>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000092814950090</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2001 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>96 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>01-0016453</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>BACKGROUND: The role of estrogen in motor, cognitive, and behavioral functions in Parkinson's disease (PD) remains unclear. OBJECTIVES/METHODS: To determine differences in functional, cognitive, and behavioral patterns between estrogen users and non-users, we performed an observational study on 10,145 elderly women with PD using the Systematic Assessment in Geriatric drug use via Epidemiology (SAGE) database. The SAGE database consists of the Minimum Data Set (MDS), data collected on a cross-section of over 400,000 nursing home (NH) residents in five US states. Using a cross-sectional study design, we evaluated the demographics, physical and cognitive function, and mortality rates of women with PD who received estrogen (n = 195) versus those who did not receive estrogen (n = 9950). RESULTS: Independent of age, estrogen users were less cognitively impaired and more independent in their activities of daily living. Surprisingly, more estrogen users were depressed and more likely to be on an antidepressant than non-users. One-year death rates were comparable between estrogen users and non-users. CONCLUSION: This study supports the growing number of recent data suggesting estrogen's potential beneficial effects on PD motor and cognitive functions.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02O</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Oestrogène</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Estrogen</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Estrógeno</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Utilisation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Use</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Utilización</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Etablissement troisième âge</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Homes for the aged</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Establecimiento tercera edad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Démence</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Dementia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Demencia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Capacité fonctionnelle</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Functional capacity</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Capacidad funcional</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Mortalité</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Mortality</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Mortalidad</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Etat dépressif</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Depression</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Estado depresivo</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Traitement substitutif</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Replacement therapy</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Tratamiento sustitutivo</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Hormonothérapie</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Hormon replacement therapy</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>61</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>61</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>61</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Trouble cognition</s0>
<s5>62</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Cognitive disorder</s0>
<s5>62</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Trastorno cognitivo</s0>
<s5>62</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Trouble humeur</s0>
<s5>69</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Mood disorder</s0>
<s5>69</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Trastorno humor</s0>
<s5>69</s5>
</fC07>
<fN21><s1>008</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 01-0016453 INIST</NO>
<ET>Estrogen use among nursing home residents with a diagnosis of Parkinson's disease</ET>
<AU>FERNANDEZ (Hubert H.); LAPANE (Kate L.)</AU>
<AF>Department of Clinical Neurosciences and Center for Gerontology and Health Care Research, Brown University School of Medicine/Providence, Rhode Island/Etats-Unis (1 aut.); Division of Neurology, Memorial Hospital of Rhode Island/Rhode Island/Etats-Unis (1 aut.); Department of Community Health and Center for Gerontology and Health Care Research, Brown University School of Medicine/Providence, Rhode Island/Etats-Unis (2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2000; Vol. 15; No. 6; Pp. 1119-1124; Bibl. 96 ref.</SO>
<LA>Anglais</LA>
<EA>BACKGROUND: The role of estrogen in motor, cognitive, and behavioral functions in Parkinson's disease (PD) remains unclear. OBJECTIVES/METHODS: To determine differences in functional, cognitive, and behavioral patterns between estrogen users and non-users, we performed an observational study on 10,145 elderly women with PD using the Systematic Assessment in Geriatric drug use via Epidemiology (SAGE) database. The SAGE database consists of the Minimum Data Set (MDS), data collected on a cross-section of over 400,000 nursing home (NH) residents in five US states. Using a cross-sectional study design, we evaluated the demographics, physical and cognitive function, and mortality rates of women with PD who received estrogen (n = 195) versus those who did not receive estrogen (n = 9950). RESULTS: Independent of age, estrogen users were less cognitively impaired and more independent in their activities of daily living. Surprisingly, more estrogen users were depressed and more likely to be on an antidepressant than non-users. One-year death rates were comparable between estrogen users and non-users. CONCLUSION: This study supports the growing number of recent data suggesting estrogen's potential beneficial effects on PD motor and cognitive functions.</EA>
<CC>002B02O</CC>
<FD>Parkinson maladie; Oestrogène; Utilisation; Etablissement troisième âge; Démence; Capacité fonctionnelle; Mortalité; Etat dépressif; Etude comparative; Traitement substitutif; Epidémiologie; Personne âgée; Hormonothérapie</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Trouble neurologique; Trouble cognition; Trouble humeur</FG>
<ED>Parkinson disease; Estrogen; Use; Homes for the aged; Dementia; Functional capacity; Mortality; Depression; Comparative study; Replacement therapy; Epidemiology; Elderly; Hormon replacement therapy</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Neurological disorder; Cognitive disorder; Mood disorder</EG>
<SD>Parkinson enfermedad; Estrógeno; Utilización; Establecimiento tercera edad; Demencia; Capacidad funcional; Mortalidad; Estado depresivo; Estudio comparativo; Tratamiento sustitutivo; Epidemiología; Anciano</SD>
<LO>INIST-20953.354000092814950090</LO>
<ID>01-0016453</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B14 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002B14 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:01-0016453
   |texte=   Estrogen use among nursing home residents with a diagnosis of Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Estrogen use among nursing home residents with a diagnosis of Parkinson's disease

Estrogen use among nursing home residents with a diagnosis of Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri